If you liked this article you might like

Generics Drop Across Board as DOJ Inquiry Expands
Teva Divests More Assets to Win EC Approval for Allergan Generics Deal
Changing Landscape for Generic-Drug Makers Creates Opportunities
Dr Reddy's Laboratories (RDY) Highlighted As Weak On High Volume